BioCentury | Oct 13, 2020
Product Development
Data Bytes: coronavirus-targeted small molecules
...have SARS-CoV-2 3CLpro inhibitors in preclinical development: Anivive Lifesciences Inc., Cocrystal Pharma Inc. (NASDAQ:COCP), Insilico Medicine Inc., Pardes Biosciences Inc....
